Cardiovascular-liver-metabolic multimorbidity

2 papers5 findings

Humans2

Associations

4

CTI-BMI

upin humans1OR 3.46

1 study

CTI-BMI predicts cardiovascular-liver-metabolic multimorbidity in humans (AUC 0.638, 95% CI 0.611-0.664).
Humansapproximately four-yearn = 6,534
Composite C-reactive protein-triglyceride-glucose adiposity indices and incident cardiovascular-liver-metabolic multimorbidity: a prospective cohort study
Cardiovascular diabetology26 Aug 2026
CTI-BMI raises the risk of cardiovascular-liver-metabolic multimorbidity in humans (Q4 OR 3.46, P <0.001).
Humansfully adjusted modelapproximately four-yearn = 6,534
Composite C-reactive protein-triglyceride-glucose adiposity indices and incident cardiovascular-liver-metabolic multimorbidity: a prospective cohort study
Cardiovascular diabetology26 Aug 2026

More on CTI-BMI

CHG-BMI

upin humans1

1 study

CHG-BMI predicts cardiovascular-liver-metabolic multimorbidity in humans (AUC 0.643, 95% CI 0.616-0.669).
Humansn = 6,534
The cholesterol, high-density lipoprotein, and glucose index and its derivatives related to obesity and inflammation as novel metabolic markers for predicting new-onset cardiovascular-liver-metabolic multimorbidity: A prospective cohort study
Journal of diabetes investigation9 Oct 2026

More on CHG-BMI

CHG index

upin humans1OR 1.64

1 study

CHG index raises the risk of cardiovascular-liver-metabolic multimorbidity in humans (OR 1.64, 95% CI 1.22-2.22).
Humanshighest vs lowest quartilen = 6,534
The cholesterol, high-density lipoprotein, and glucose index and its derivatives related to obesity and inflammation as novel metabolic markers for predicting new-onset cardiovascular-liver-metabolic multimorbidity: A prospective cohort study
Journal of diabetes investigation9 Oct 2026

More on CHG index

CTI-CVAI

upin humans1OR 2.37

1 study

CTI-CVAI raises the risk of cardiovascular-liver-metabolic multimorbidity in humans (Q4 OR 2.37, P <0.001).
Humansfully adjusted modelapproximately four-yearn = 6,534
Composite C-reactive protein-triglyceride-glucose adiposity indices and incident cardiovascular-liver-metabolic multimorbidity: a prospective cohort study
Cardiovascular diabetology26 Aug 2026

More on CTI-CVAI

Latest

2 in 12 months

Journal of Diabetes InvestigationYesterday

The cholesterol, high-density lipoprotein, and glucose index and its derivatives related to obesity and inflammation as novel metabolic markers for predicting new-onset cardiovascular-liver-metabolic multimorbidity: A prospective cohort study

Cohort study of 6,534 peopleCardiovascular disease

Cardiovascular Diabetology29 Aug

Composite C-reactive protein-triglyceride-glucose adiposity indices and incident cardiovascular-liver-metabolic multimorbidity: a prospective cohort study

Cohort study of 6,534 peopleGlucose